The clinical trial, to be conducted in two phases, will evaluate the safety and efficacy of Mesocel for the treatment of patients with moderate to severe Covid-19
It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
It comes with a prime focus on infection control and patient flow as the primary infrastructure design aspects - the need of the hour and must-have during a pandemic.
The pharma park will be built at an estimated cost of Rs 34.94 crore and will be spread over 50 acres at Chanho close to Ranchi
It has been built at a cost of Rs 19.5 crores through internal accruals of the Malabar Institute of Medical Sciences (MIMS)
The hospital through its network performs more than 10,000 joint replacement surgeries annually
The institute will provide the world’s first unique and comprehensive capability to predict, prevent, respond and to recover from future pandemics
HTL will build, validate and operate a botulinum manufacturing facility in the US
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
Subscribe To Our Newsletter & Stay Updated
